Abbott Laboratories ABT
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Abbott Laboratories (ABT) Business Model and Operations Summary
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Key Insights
Abbott Laboratories (ABT) Core Market Data and Business Metrics
Latest Closing Price
$131.93Market Cap
$225.32 BillionPrice-Earnings Ratio
17.27Total Outstanding Shares
1.73 Billion SharesTotal Employees
114,000Dividend
$0.59 Per Share QuarterlyIPO Date
April 19, 1949SIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
100 Abbott Park Road, Abbott Park, IL, 60064-3500
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 8,320,551 Shares | 2.63 | 3/14/2025 | 21,877,008 Shares |
| 5,833,190 Shares | 3.93 | 2/28/2025 | 22,932,064 Shares |
| 5,770,708 Shares | 3.87 | 2/14/2025 | 22,311,682 Shares |
| 9,242,653 Shares | 1.97 | 1/31/2025 | 18,239,173 Shares |
| 4,868,228 Shares | 3.07 | 1/15/2025 | 14,968,960 Shares |
| 5,059,409 Shares | 2.83 | 12/31/2024 | 14,317,431 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $-5.40 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-2.34 Billion |
| Net Cash Flow From Operating Activities, Continuing | $8.56 Billion |
| Net Cash Flow | $816 Million |
| Net Cash Flow From Financing Activities, Continuing | $-5.40 Billion |
| Net Cash Flow, Continuing | $816 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Diluted Average Shares | $1.75 Billion |
| Selling, General, and Administrative Expenses | $11.70 Billion |
| Cost Of Revenue | $18.71 Billion |
| Income Tax Expense/Benefit | $-6.39 Billion |
| Revenues | $41.95 Billion |
| Costs And Expenses | $35.13 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $13.34 Billion |
| Comprehensive Income/Loss | $13.34 Billion |
| Other Comprehensive Income/Loss | $13.34 Billion |
| Other Comprehensive Income/Loss Attributable To Parent | $-67 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Intangible Assets | $6.65 Billion |
| Equity Attributable To Noncontrolling Interest | $237 Million |
| Wages | $1.70 Billion |
| Noncurrent Liabilities | $19.36 Billion |
| Inventory | $6.19 Billion |
| Long-term Debt | $14.13 Billion |
Historical Dividends
Current dividend: $0.59 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 21, 2025 | May 15, 2025 | Apr 15, 2025 | $0.59 | Quarterly |
| Dec 13, 2024 | Feb 14, 2025 | Jan 15, 2025 | $0.59 | Quarterly |
| Sep 19, 2024 | Nov 15, 2024 | Oct 15, 2024 | $0.55 | Quarterly |
| Jun 14, 2024 | Aug 15, 2024 | Jul 15, 2024 | $0.55 | Quarterly |
| Feb 16, 2024 | May 15, 2024 | Apr 15, 2024 | $0.55 | Quarterly |
| Dec 15, 2023 | Feb 15, 2024 | Jan 12, 2024 | $0.55 | Quarterly |